Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin

Authors
Publication date
1 January 2008
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Copenhagen University Research Information System

    redirect
    oaioai:pure.atira.dk:publications...
    Last time updated on 18/12/2019